Balchem : Announces Conference Call for First Quarter 2022 Financial Results
April 15, 2022 at 07:11 am EDT
Share
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, April 29th at 11:00 AM Eastern Time (ET) to review First Quarter 2022 results.
We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the call through end of day Friday, May 13, 2022. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use conference ID #13729002.
Ted Harris, Chairman, CEO, and President of Balchem said, "The Balchem team delivered an excellent fourth quarter performance, setting new records for sales and adjusted EBITDA, while delivering solid sales growth in all three reporting segments and consolidated organic volume growth of almost 8%. We also delivered strong cash flows, showing consistency in translating our profits into cash."
Balchem Announces Conference Call for 4th Quarter 2021 Financial Results
Join Ted Harris, Chairman of the Board, CEO and President and Martin Bengtsson, CFO on Friday, February 18th at 11:00 AM Eastern Time (ET) to review 4th Quarter 2021 results.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Balchem Corporation published this content on 15 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 15 April 2022 11:10:11 UTC.
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company's segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. Through Specialty Products, it re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
BALCHEM CORPORATION 
